Canadian pharmacy Shows Obese Teens Need to Lose Weight and Vitamin D Intake

Dr. Zeev Harel, a pediatrician specialist on adolescent medicine at Hasbro Children's Hospital in Providence, R.I., authored the study on the association between teen obesity and their lack of vitamin D.  The study was published in the May issue of the Journal of Adolescent Health.  That is, low levels of vitamin D are common among obese adolescents, and might need to buy Lorcaserin online for weight-loss purposes. 

"It is possible that the association between obesity and low vitamin D status is indirect, arising from obese individuals having fewer outdoor activities than lean individuals and, therefore, less exposure to sun," the researchers highlighted. "Likewise, it is also possible that obese individuals do not consume enough foods that contain vitamin D." 

The study involved 68 obese adolescents and results show that 100 percent of the girls have low vitamin D levels – 72 percent deficient and 28 percent insufficient; on the other hand 91 percent of the boys have low vitamin D – 69 percent deficient and 22 percent insufficient. 

The obese teens with low vitamin D underwent a treatment using Canada drugs.  And, their vitamin D levels were measured again, though results show increase but only 28 percent reached the normal level, which means 72 percent even with treatment did not attain normal vitamin D level. 

Study researchers suggested that poor response to vitamin D treatment could be caused by the fast vitamin D seizure by the participants’ body fats. 

"The prevalence of low vitamin D status among obese adolescents in this study is greater than previously reported for this age group," according to Dr. Harel. 

Researchers recommend for a rigorous monitoring on the vitamin D levels among obese teens; and, to conduct a further research in order to identify whether normal vitamin D level could boost their immune system to get rid of health risks brought by their abnormal weight, and eventually avoid going to Canadian pharmacy  for medication. 

Weight loss, in the context of medicine, health or physical fitness, is a reduction of the total body mass, due to a mean loss of fluid, body fat or adipose tissue and/or lean mass, namely bone mineral deposits, muscle, tendon and other connective tissue. It can occur unintentionally due to an underlying disease or can arise from a conscious effort to improve an actual or perceived overweight or obese state. 

Unintentional weight loss occurs in many diseases and conditions, including some very serious diseases such as cancer, AIDS, and a variety of other diseases. 

Poor management of type 1 diabetes mellitus, also known as insulin-dependent diabetes mellitus (IDDM), leads to an excessive amount of glucose and an insufficient amount of insulin in the bloodstream. This triggers the release of triglycerides from adipose (fat) tissue and catabolism (breakdown) of amino acids in muscle tissue. This results in a loss of both fat and lean mass, leading to a significant reduction in total body weight. Untreated type 1 diabetes mellitus can produce weight loss. In addition to weight loss due to a reduction in fat and lean mass, fluid loss can be triggered by illnesses such as diabetes, certain medications, lack of fluid intake or other factors. Fluid loss in addition to reduction in fat and lean mass exacerbates the risk for cachexia.